Skip to main content
. Author manuscript; available in PMC: 2023 Jun 16.
Published in final edited form as: Radiat Res. 2022 May 1;197(5):491–508. doi: 10.1667/RADE-21-00059.1

Table 5.

Excess relative risk estimates for all solid cancer mortality by calendar period or age at exposure under linear-quadratic dose-response model: LSS, 1958–2009

Calendar period Age at exposure

Year Deaths Q/L P a Year Deaths Q/L P a
95% CI 95% CI
Males Males
 1958–1987 3,731 0.29b 0.805  20–83 4,578 −0.04 0.648
Undefined −0.35 to 4.53
 1988–2009 3,793 5.99 0.024  0–19 2,946 7.88 0.015
≤−1.54 or ≥0.18 NE or ≥0.23
 P c 0.425 0.108
Females Females
 1958–1987 3,885 0.22 0.643  20–83 6,010 0.28 0.583
−0.13 to 1.71 −0.13 to 3.21
 1988–2009 4,010 4.97 0.003  0–19 1,885 1.99 0.006
≤−2.31 or ≥0.38 ≤−4.00 or ≥0.26
P c 0.063 0.186

Note. LSS, Life Span Study. ERR, excess relative risk. L, linear dose coefficient. Q, quadratic dose coefficient. Q/L, ratio of quadratic to linear dose coefficient or curvature. 95% CI, confidence interval. NE, not estimable.

a

P value for quadratic departure from linearity.

b

Curvature estimates are from linear-quadratic ERR models with parametric background (common to both calendar periods or ages at exposure), multiplicative adjustment for smoking, independent effect modification by sex, sex-specific attained age, age at exposure, and high dose.

c

P value for heterogeneity in sex-specific curvature by calendar period or age at exposure.